Home MarketAdinath Bio-Labs Ltd.

Adinath Bio-Labs Ltd. Stock Info: As on 2017-03-07 00:00:00

NO DATA AVAILABLE

Bse

0.30

-0.01(-3.23%)
Change %
52 Week Range
0.19
8.00
0.35
2.00
Open0.30
Day's Range0.29 - 0.33
Value Traded (in ₹ Cr.) 0.00

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 56,838,005.00 25.75%
Mutual Funds/UTI 0.00 0.00%
FII 0.00 0.00%
Employee 0.00 0.00%
Public 100,597,848.00 45.57%
Government 0.00 0.00%
Others 63,306,707.00 28.68%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 5.21
Basic EPS (Rs.) 0.01
Cash EPS 0.01
BVPerShare Excl 1.33
Operating Revenue 0.03
PBDITPerShare 0.02
Dividend 0.00
NPPerShare 0.01
Current Ratio 3.96
Quick Ratio 3.96
PriceToBV 0.14
Earnings 0.03
PBDIT Margin 57.66
PBT Margin 37.70
NP Margin 17.84
Return On Assets 0.48
Retention Ratios 0.00
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 1.00
Total Expenses 0.69
EBITDA 0.46
PBT 0.30
PAT 0.14
Net Income 0.14
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 0.37
Total Expenses 0.34
EBITDA -0.06
PBT 0.02
PAT 0.02
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 22.07
Net worth 29.30
Investments 0.56
Total Liability 29.49
Total debt 0.00
Net block 2.42
Total Assets 29.49
Parameter Sep-16 (₹ Cr.) 6M % change
Total share capital 22.07
Net worth 29.44
Investments 0.56
Total Liability 29.59
Total debt 0.00
Net block 2.50
Total Assets 29.59
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

535.05 535.15 -0.02
525.05537.3

Abbott India Ltd.

4977.5 4858.7 2.45
4810.055049

Ajanta Pharma Ltd.

1329.2 1327.15 0.15
1281.151362.3

Albert David Ltd.

361.2 323.55 11.64
286.1374

Alembic Ltd.

39.35 39.25 0.25
3940.2

Alembic Pharmaceuticals Ltd.

515.5 514.3 0.23
507.4520.4

Alkem Laboratories Ltd.

1987.9 1974.45 0.68
19442013.85
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

56.5 53.35 5.9
44.0558.4

Aarti Drugs Ltd.

532.1 532 0.02
513.4537

Aayush Food & Herbs Ltd.

47.7 47.9 -0.42
45.0552.7

Abbott India Ltd.

4968.65 4861.15 2.21
4825.655085

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Advik Laboratories Ltd.

5.7 5.99 -4.84
5.76.27
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities -2.60
Cash from investing activities 2.58
Cash from financing activities 0.00
Net change in cash -0.02

Stock Held By Mutual Fund Schemes

Excel Industries Q2 net profit jumps 60.26% at Rs 11.01 cr

The company reported standalone net profit of Rs 11.01 crore for the quarter ended September 30, 2017 as compared to Rs 6.87 crore in the same period last year, registering a year-on-year growth of 60.26 per cent. Net revenue of the company rose moderately by 6.02 per cent at Rs 130.02 crore in July-September quarter of this fiscal as against Rs 122.64 crore in the corresponding period last year. During July-September quarter, operating expenses dropped by 0.72 per cent to Rs 108.27 crore from Rs 109.05 crore in year ago period. Other Income dipped by 71.76 per cent at Rs 0.24 crore versus (Sep'16 Rs 0.85 crore). Operating Profit surged by 45.68 per cent to Rs 21.75 crore as against Rs 14.93 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 37.36 per cent in September quarter. Interest declined by 47.90 per cent y-o-y to Rs 1.61 crore, while Taxation increased by 156.31 per cent at Rs 5.69 crore (Sep'16 Rs 2.22 crore).

24-11-2017 16:50

Skyline Millars posts Q2 net loss of Rs 0.16 cr

The company reported standalone net loss during the quarter stood at Rs 0.16 crore compared to net profit of Rs 0.53 crore in the previous year quarter. Net revenue of the company rose two fold by 245.45 per cent at Rs 1.14 crore in July-September quarter of this fiscal as against Rs 0.33 crore in the corresponding period last year. During July-September quarter, operating expenses increased by 7.37 per cent to Rs 1.02 crore from Rs 0.95 crore in year ago period. Other Income dipped by 99.43 per cent at Rs 0.01 crore versus (Sep'16 Rs 1.74 crore). Operating Profit surged by 119.35 per cent to Rs 0.12 crore as against Rs -0.62 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 105.56 per cent in September quarter.

24-11-2017 16:40

Kingfa Science & Technology Q2 net profit up 21.77%

The company reported standalone net profit of Rs 5.09 crore for the quarter ended September 30, 2017 as compared to Rs 4.18 crore in the same period last year, registering a year-on-year growth of 21.77 per cent. Net revenue of the company rose substantially by 24.78 per cent at Rs 139.87 crore in July-September quarter of this fiscal as against Rs 112.09 crore in the corresponding period last year. During July-September quarter, operating expenses increased by 23.44 per cent to Rs 130.01 crore from Rs 105.32 crore in year ago period. Other Income grew by 1058.33 per cent at Rs 1.15 crore versus (Sep'16 Rs -0.12 crore). Operating Profit surged by 45.86 per cent to Rs 9.86 crore as against Rs 6.76 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 16.92 per cent in September quarter. Interest grew by 257.75 per cent y-o-y to Rs 1.12 crore, while Taxation increased by 68.61 per cent at Rs 3.76 crore (Sep'16 Rs 2.23 crore).

24-11-2017 16:30

Valiant wins orders worth Rs 5 cr for metro projects

Valiant Communications on Friday said it has received the product approvals and letter of intents for supply of its communication solutions for Kolkata Metro Rail Corporation and Dedicated Freight Corridor projects for western Region. “The gross value of the projects exceeds Rs 5 crore,” Valiant Communications said in a filing to the Bombay Stock Exchange. Commenting on the development, Inder Mohan Sood, Managing Director said: “These are significant developments, as it also opens up the railway sector for the company to participate in the upgradation of Indian Railways.” Meanwhile, shares of company closed trade at Rs 84.00 apiece, up 6.94 per cent, on the BSE today.

24-11-2017 16:16

Alexander Stamps Q2 net profit up 6.25% at Rs 0.17 cr

The company reported standalone net profit of Rs 0.17 crore for the quarter ended September 30, 2017 as compared to Rs 0.16 crore in the same period last year, registering a year-on-year growth of 6.25 per cent. Net revenue of the company declined substantially by 57.74 per cent at Rs 1.31 crore in July-September quarter of this fiscal as against Rs 3.10 crore in the corresponding period last year. During July-September quarter, operating expenses dropped by 62.76 per cent to Rs 1.08 crore from Rs 2.90 crore in year ago period. Operating Profit surged by 15.00 per cent to Rs 0.23 crore as against Rs 0.20 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 169.71 per cent in September quarter. Taxation increased by 40.00 per cent at Rs 0.07 crore (Sep'16 Rs 0.05 crore).

24-11-2017 15:10

Adinath Bio-Labs Ltd - Standalone Financial Results, Limited Review Report for December 31, 2016

Adinath Bio-Labs Ltd has informed BSE about :

1. Standalone Financial Results for the period ended December 31, 2016

2. Standalone Limited Review for the period ended December 31, 2016

10-Feb-2017 12:47 PM

Adinath Bio-Labs Ltd - Board Meeting Intimation for Results & Closure of Trading Window

Adinath Bio-Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 10, 2017, inter alia, to consider the following business as under:-

- To consider and approve Unaudited financial results for the 3rd quarter ended 31st December, 2016.

Further, the Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Code of Conduct farmed by the Company shall be closed for all designated persons of the Company and their relatives from February 01, 2017 to February 12, 2017 (both days inclusive).

30-Jan-2017 07:03 PM

Adinath Bio-Labs Ltd - Shareholding for the Period Ended December 31, 2016

Adinath Bio-Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016.

18-Jan-2017 06:04 PM

Adinath Bio-Labs Ltd - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended De

Adinath Bio-Labs Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

13-Jan-2017 10:48 AM

Adinath Bio-Labs Ltd - Standalone Financial Results, Limited Review Report for December 31, 2016

Adinath Bio-Labs Ltd has informed BSE about :

1. Standalone Financial Results for the period ended December 31, 2016

2. Standalone Limited Review for the period ended December 31, 2016

10-Feb-2017 12:47 PM

Adinath Bio-Labs Ltd - Board Meeting Intimation for Results & Closure of Trading Window

Adinath Bio-Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 10, 2017, inter alia, to consider the following business as under:-

- To consider and approve Unaudited financial results for the 3rd quarter ended 31st December, 2016.

Further, the Trading Window under SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Code of Conduct farmed by the Company shall be closed for all designated persons of the Company and their relatives from February 01, 2017 to February 12, 2017 (both days inclusive).

30-Jan-2017 07:03 PM

Adinath Bio-Labs Ltd - Shareholding for the Period Ended December 31, 2016

Adinath Bio-Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016.

18-Jan-2017 06:04 PM

Corporate Details

About Management

2008

- The Company has splits its face value from Rs10/- to Rs1/-.

2009

--Registered Office of the Company has been shifted form "Suite No.18, 2 India Exchange Place, Kolkata - 700001" to "4, N.S.Road, 1st Floor, Kolkata - 700001."

Registered Office

4, N. S. Road, 1st Floor

033-22315718,,,      033-22315718,

investors@adinathbio.com

http://www.adinathbio.com

Registrar Details

Adroit Corporate Service (P) Ltd.